公开(公告)号：EP2760335B1

公开(公告)日：2020-03-18

申请号：EP12836194.6

申请日：2012-09-27

申请人： Abbott Diabetes Care, Inc.

发明人： CROUTHER, Nathan C. ,  DUNN, Timothy C.

IPC分类号： A61B5/145

公开(公告)号：EP2760335A1

公开(公告)日：2014-08-06

申请号：EP12836194.6

申请日：2012-09-27

申请人： Abbott Diabetes Care, Inc.

发明人： CROUTHER, Nathan C. ,  DUNN, Timothy C.

IPC分类号： A61B5/05

CPC分类号： A61B5/14532 ,  A61B5/14546 ,  A61B5/7282 ,  A61B5/742 ,  G16H40/63

摘要： Generally, methods of analyte monitoring management, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data and analyzing the analyte measurement data for health related parameters. Recommendations are determined for creating or modifying a treatment program based on the analysis, and provided within a user-interface that enables a user to create or modify the treatment program. Further, generally, methods of for managing analyte measurement data, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data that represent data collected over a time period, and analyzing the analyte measurement data for analyte episodes within that time period. Threshold based episodes and/or rate-of-change based episodes may be determined.

摘要翻译： 一般而言，提供了分析物监测管理的方法和与其相关的制造物品。 该方法包括接收分析物测量数据并分析健康相关参数的分析物测量数据。 根据分析确定建立或修改治疗程序的建议，并在用户界面内提供使用户能够创建或修改治疗程序的建议。 此外，通常提供了用于管理分析物测量数据的方法以及与其相关的制造物品的方法。 该方法包括接收表示在一段时间内收集的数据的分析物测量数据，并分析该时间段内用于分析物发作的分析物测量数据。 基于阈值的事件和/或基于变化率的事件可以被确定。

公开(公告)号：EP2972379B1

公开(公告)日：2018-06-13

申请号：EP14762430.8

申请日：2014-03-15

申请人： Abbott Diabetes Care, Inc.

发明人： BUDIMAN, Erwin S. ,  HAYTER, Gary A. ,  DONIGER, Kenneth J. ,  DUNN, Timothy C. ,  CROUTHER, Nathan C. ,  BERMAN, Glenn H. ,  WOLPERT, Howard A.

IPC分类号： A61B5/145 ,  G06F19/00 ,  G01N33/66

CPC分类号： A61B5/7275 ,  A61B5/14532 ,  A61B5/4836 ,  A61B5/4848 ,  A61B5/7282 ,  A61B5/742 ,  A61B5/746 ,  G01N33/66 ,  G06F19/00 ,  G06F19/34 ,  G06F19/3456 ,  G16H15/00 ,  G16H20/10 ,  G16H50/30

摘要： A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.

公开(公告)号：EP2972379A1

公开(公告)日：2016-01-20

申请号：EP14762430.8

申请日：2014-03-15

申请人： Abbott Diabetes Care, Inc.

发明人： BUDIMAN, Erwin S. ,  HAYTER, Gary A. ,  DONIGER, Kenneth J. ,  DUNN, Timothy C. ,  CROUTHER, Nathan C. ,  BERMAN, Glenn H. ,  WOLPERT, Howard A.

IPC分类号： G01N33/66 ,  A61B5/145 ,  G06F19/00

CPC分类号： A61B5/7275 ,  A61B5/14532 ,  A61B5/4836 ,  A61B5/4848 ,  A61B5/7282 ,  A61B5/742 ,  A61B5/746 ,  G01N33/66 ,  G06F19/00 ,  G06F19/34 ,  G06F19/3456 ,  G16H15/00 ,  G16H20/10 ,  G16H50/30

摘要： A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.

摘要翻译： 系统和方法提供了基于葡萄糖数据在一段时间内的动态葡萄糖分布来确定血糖风险的葡萄糖报告，基于葡萄糖的中位数和变异性的葡萄糖控制评估和高葡萄糖变异性指标。 显示了可以看到葡萄糖水平的时间段。 中位葡萄糖目标和低葡萄糖系提供与葡萄糖变异性相结合，提供了提高或降低中位数目标的效果。 低糖的可能性，中位葡萄糖与目标相比，葡萄糖低于中位数的变异性提供了基于葡萄糖数据的概率。 可以看到模式，并为治疗提供指导。